SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: idahoranch1 who wrote (289)12/18/2004 1:28:03 PM
From: mhubs  Read Replies (1) of 371
 
Idaho: Hello, you may recall me as yet another Yahoo board escapee. Good to hear from you here. I look forward to meaningful dialogue as we move along. On the company itself, I am of a mind that these next couple of months will be interesting from the standpoint of a substantive relationship with a partner. Your overview of the science is spot on as always...I'm more on the business side and the opportunity that CD22 and the autoimmune disease market has presented is not insignificant. My read of the company is that they perceive that the opportunity is here now and delay is not wise. There seems also to have been a lesson learned in the dealings with the FDA. The good Doctor's reputation over the years within the regulatory environment has not been the best (understatement)and things, I think, are apparently going somewhat more smoothly these days. I really think the atmosphere is here for a deal of substance in the short term.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News